Oncology · Phase II

Top sponsors

• First People's Hospital 261 programs
• Chinese Academy of 198 programs
• George Institute for 118 programs
• United Therapeutics Europe 112 programs
• Telethon Foundation 91 programs
• Takeda 79 programs
• Regeneron UK 71 programs
• MSD Merck Sharp 63 programs
• Ningbo Cancer Hospital 62 programs
• Anaxis Pharma 57 programs
• AstraZeneca 52 programs
• HOFFMANN-LA ROCHE 50 programs

1. SOX Chemotherapy

   Xiyuan Hospital of China Academy of Chinese Medical Sciences

   Gastroesophageal Junction Adenocarcinoma

   phase 2 · small molecule · active

   1 trial →

2. SPI-62 as a Treatment for Hypercortisolism Related to a Benign Adrenal Tumor

   Lacuna Pharma Pty Ltd

   Hypercortisolism related to benign adrenal tumour

   phase 2 · other · active

   1 trial →

3. SPLFIO-174

   The George Institute

   Non-small cell lung cancer (NSCLC): - Locally advanced NSCLC where participants are not candidates for surgical resection and/or definitive chemoradiation, or - Metastatic NSCLC

   phase 2 · small molecule · active

   1 trial →

4. SPON - 1751-19

   Cardiff Oncology

   Blood cancer

   phase 2 · small molecule · active

   1 trial →

5. SRF388

   Coherus Oncology

   Hepatocellular Carcinoma

   phase 2 · small molecule · completed

   1 trial →

6. SRF617

   Arcus Biosciences

   Metastatic Castration-resistant Prostate Cancer

   phase 2 · small molecule · terminated

   1 trial →

7. SSGJ-706+XELOX

   Sunshine Guojian Pharmaceutical (Shanghai) Co.,

   Gastric/Gastroesophageal Junction Adenocarcinoma

   phase 2 · small molecule · active

   1 trial →

8. SSGJ-707

   Sunshine Guojian Pharmaceutical (Shanghai) Co.,

   Metastatic Colorectal Cancer

   phase 2 · small molecule · active

   1 trial →

9. SSGJ-707

   Sunshine Guojian Pharmaceutical (Shanghai) Co.,

   Advanced/recurrent Endometrial Cancer and Platinum-resistant Ovarian Cancer

   phase 2 · small molecule · active

   1 trial →

10. STC-15 in combination with toripalimab

    Coherus Oncology

    Solid Tumor

    phase 2 · other · active

    1 trial →

11. STML-ELA-0322

    Stemline Therapeutics B.V.

    metastatic breast cancer

    phase 2 · small molecule · active

    1 trial →

12. STRO-002

    SUTRO BIOPHARMA, INC.

    Neoplasm Malignant

    phase 2 · mab · completed

    1 trial →

13. STRO-002-GM3

    SUTRO BIOPHARMA, INC.

    Advanced Epithelial Ovarian Cancer (including Fallopian Tube or Primary Peritoneal cancers)

    phase 2 · small molecule · active

    1 trial →

14. SU2C-001

    BRIGHT MINDS BIOSCIENCES INC.

    Previously Treated Metastatic Pancreatic Cancer

    phase 2 · small molecule · completed

    1 trial →

15. SV-BR-1-GM

    BriaCell Therapeutics

    Breastcancer

    phase 2 · mab · completed

    1 trial →

16. SX-682

    United Therapeutics Europe Ltd

    Metastatic Castrate-Resistant Prostate Cancer (mCRPC)

    phase 2 · small molecule · active

    1 trial →

17. SY-1425, AZACITIDINE

    Lacuna Pharma Pty Ltd

    Acute Myeloid Leukemia (AML) Myelodysplastic Syndrome (MDS)

    phase 2 · small molecule · active

    1 trial →

18. SY-1425-202

    Lacuna Pharma Pty Ltd

    RARA-positive acute myeloid leukemia

    phase 2 · small molecule · active

    1 trial →

19. SYSUCC-CMY-2022-0416

    The First People's Hospital of Lianyungang

    Nasopharyngeal Carcinoma

    phase 2 · small molecule · active

    1 trial →

20. Sacituzumab Tirumotecan

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Extensive-Stage Small Cell Lung Cancer

    phase 2 · small molecule · active

    1 trial →

21. Sacituzumab Tirumotecan and Limertinib

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    EGFR-mutant Non-small Cell Lung Cancer

    phase 2 · small molecule · active

    1 trial →

22. Sacituzumab Tirumotecan in combination with tislelizumab

    The First People's Hospital of Lianyungang

    Esophageal Squamous Cell Carcinoma

    phase 2 · small molecule · active

    1 trial →

23. Sacituzumab tirumotecan

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    TNBC - Triple-Negative Breast Cancer

    phase 2 · small molecule · active

    1 trial →

24. Safety and efficacy of IMM-101 combined with...

    Disc Medicine

    Limited metastatic pancreatic cancer

    phase 2 · other · active

    1 trial →

25. Sandwich stratergy

    The First People's Hospital of Lianyungang

    Acute Lymphobkastic Leukemia

    phase 2 · other · active

    1 trial →

26. Saruparib

    AstraZeneca AB

    Advanced/Recurrent Ovarian cancer

    phase 2 · small molecule · active

    1 trial →

27. Sasanlimab Prefilled syringe

    Pfizer

    Carcinoma, Non-Small-Cell Lung

    phase 2 · small molecule · terminated

    1 trial →

28. Sativex

    Jazz Pharmaceuticals Ireland Limited

    Cancer

    phase 2 · small molecule · completed

    2 trials →

29. Savolitinib

    The First People's Hospital of Lianyungang

    Non-small Cell Lung Cancer

    phase 2 · small molecule · active

    1 trial →

30. Self-hypnotic Relaxation

    United Therapeutics Europe Ltd

    Breast Cancer

    phase 2 · other · completed

    1 trial →

31. Selinexor

    Karyopharm Therapeutics Inc

    Acute Myeloid Leukemia (AML)

    phase 2 · small molecule · completed

    3 trials →

32. Selinexor

    Karyopharm Therapeutics Inc

    Peripheral T-cell Lymphoma (PTCL)

    phase 2 · small molecule · terminated

    1 trial →

33. Selinexor

    Karyopharm Therapeutics Inc

    Carcinoma, Neuroendocrine

    phase 2 · small molecule · completed

    1 trial →

34. Selinexor

    Karyopharm Therapeutics Inc

    Acute Myeloid Leukemia (Relapsed/Refractory)

    phase 2 · small molecule · completed

    1 trial →

35. Selinexor

    Hospital Authority, Hong Kong

    Acute Myeloid Leukemia, Adult

    phase 2 · small molecule · terminated

    1 trial →

36. Selinexor

    Karyopharm Therapeutics Inc

    Relapsed or Refractory Diffuse Large B-Cell Lymphoma

    phase 2 · small molecule · terminated

    1 trial →

37. Selinexor

    Karyopharm Therapeutics Inc

    Solid Tumor Malignancy

    phase 2 · small molecule · terminated

    1 trial →

38. Selinexor

    Karyopharm Therapeutics Inc

    Recurrent Small Cell Lung Carcinoma

    phase 2 · small molecule · terminated

    1 trial →

39. Selinexor

    Karyopharm Therapeutics Inc

    Prostate Cancer

    phase 2 · small molecule · terminated

    1 trial →

40. Selinexor

    Karyopharm Therapeutics Inc

    Ovarian Carcinoma

    phase 2 · small molecule · completed

    1 trial →

41. Selinexor

    Karyopharm Therapeutics Inc

    Non-small Cell Lung Cancer

    phase 2 · small molecule · terminated

    1 trial →

42. Selinexor

    Karyopharm Therapeutics Inc

    Metastatic Colorectal Cancer

    phase 2 · small molecule · terminated

    1 trial →

43. Selinexor

    Karyopharm Therapeutics Inc

    Locally Advanced Unresectable or Metastatic Melanoma

    phase 2 · small molecule · terminated

    1 trial →

44. Selinexor

    Karyopharm Therapeutics Inc

    Leukemia

    phase 2 · small molecule · completed

    2 trials →

45. Selinexor

    Karyopharm Therapeutics Inc

    Diffuse Large B-cell Lymphoma

    phase 2 · small molecule · active

    1 trial →

46. Selinexor

    Karyopharm Therapeutics Inc

    Breast Cancer

    phase 2 · small molecule · completed

    1 trial →

47. Selinexor

    Karyopharm Therapeutics Inc

    Acute Myeloid Leukemia

    phase 2 · small molecule · completed

    1 trial →

48. Selinexor

    The First People's Hospital of Lianyungang

    Acute Myeloid Leukemia (Relapsed/Refractory)

    phase 2 · small molecule · active

    1 trial →

Frequently asked questions